Drug Profile


Alternative Names: NeoSTX

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Childrens Hospital Boston; Proteus S.A.; University of Chile
  • Class Alkaloids; Analgesics; Biological toxins; Local anaesthetics; Marine toxins; Purines; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Anaesthesia

Highest Development Phases

  • No development reported Anaesthesia

Most Recent Events

  • 23 Jan 2018 Grunenthal plans a phase I trial for Anaesthesia (Combination therapy, Monotherapy, In volunteers) (Perineural) in January 2018 (NCT03399435)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Anaesthesia(In volunteers) in USA (SC, Injection)
  • 13 Apr 2016 No recent reports on development identified - Phase-II for Anaesthesia in Chile (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top